Abstract:BACKGROUND: Lentivirus-mediated RNA interference technology has been widely used in the study of gene function because of its specificity, high inhibition efficiency and persistent effects. Virus packaging, transfection, as well as small hairpin RNA (shRNA)-coding sequence could affect the inhibition efficiency. Therefore, impact factors of RNA interference for human Bax inhibitor 1 (BI-1) was studied in this experiment. OBJECTIVE: To find the valid small interference RNA (siRNA) targeting human BI-1 gene by Lentivirus. DESIGN, TIME AND SETTING: Single sample observation was completed in Department of Medical Genetics, Basic Medical College, Peking University Health Science Center from September 2007 to December 2008. MATERIALS: 293T cell and SH-SY5Y cells were preserved in this laboratory; 4 shRNAs were designed through a use of online design tool by Ambion (www. ambion. com). METHODS: Several recombinant plasmids which expressed shRNAs targeting different regions of the BI-1 gene and labeled enhanced green fluorescent protein as a fusion gene were constructed. Four types of shRNA-expressing virions were obtained by cotransfection of shRNA-expressing plasmid and package protein-expressing plasmids into 293T cells. Green fluorescent protein expression was determined using flow cytometry to search the optimal package conditions. Real-time PCR and beta actin mRNA was used as an internal control, four types of recombinant viral supernatant and control viral supernatant were added on the SH-SY5Y cells, knock-down efficacies of the endogenous BI-1 gene were determined, and the RNA interference effective sequences were optimized. MAIN OUTCOME MEASURES: Intracellular green fluorescent protein expression rate of the cells infected with different packaging virus. RESULTS: The optimal infective packaging virus could be obtained when the ratio of plasmids pLentiLox3.7, REV, VSVG and RRE was 2:1:1:1 and the supernatants were collected 48 hours after transfection. Replacement of culture media 24 hours after transfection could increase the infection efficacy of the virions. shRNA targeting-2-17nt (start coding region) of BI-1 gene was most valid interference efficiency and could decrease the gene expression to 40%. CONCLUSION: Influencing factors of Lentivirus-mediated RNA interference technology virus packages were investigated in this study, which could be a foundation for constructing stable BI-1 knocked down neuronal cell model and for studying the abnormal expression of BI-1 related to the neuron apoptosis disease.

Construction and identification of lentiviral vector of the RNA interference of human Nanog gene

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

Expression of NANOG Gene in Acute Lymphoblastic Leukemia Cells and Construction of Lentiviral Vector Carrying NANOG Specific shRNA

Construction of recombinant lentivirus vector containing retinoic acid-induced gene G and its effect on human lung cancer A549 cell line

Construction and Identification of Lentiviral Vector-mediated RNA Interference of VEGF Gene

Construction of Eukaryotic Expression Plasmid Expressing Shrna Targeting VEGF and NGF

Construction of Eukaryotic Expression Vector of Bovine Nanog Gene and Screening for Effective siRNA

Construction and identification of a lentiviral vector for RNA interference of rat chondroitin sulfate peoteoglycan gene

Establishment of an expression vector of NgR-specific siRNA

Interference Vector Construction of nanog Gene of ES-D3 Cells and Their Interference Effect

Construction and efficacy identification of a lentiviral vector harboring RNAi based on gene NSBP1

Construction and Identification of Lentiviral Vector of Sirna Specific for CTGF

Construction and identification of lentiviral vectors expressing shRNA of NSPc1 gene

Construction of neuregulin 1-small interference RNA lentivirus vector

Construction of Recombinant Lentiviral Vector Containing Shrna for Human Neuropilin-1 Gene

Construction of a Lentiviral Vector Carrying Shrna Against HIF-1α and Generation of a GL261 Cell Line Stably Transfected with This Vector

[Cloning of Human Nanog Gene and Its Expression in COS-7L Cells].

Construction of Shrna Lentiviral Vector Targeting Human NOB1 Gene and Identification of RNAi Efficiency

Construction of Recombinant Lentivirus Vector Expressing Small Hairpin RNA Against Human Bax Inhibitor-1 Gene Expression

Construction of Mirna Interference Lentiviral Vector with Human Mir-221 Gene

Construction of Lentiviral Vector Containing Sirna Sequence of Siglec-1 and Verification of Inhibition Efficiency